SCHEMBL207168

SCHEMBL207168

Clc1ccc2n[c][nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ BACE1 P56817 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ DYRK1A Q13627 2/20 0.42
▸ F7 P08709 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ HPGD P15428 4/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PSMB8 P28062 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207659 0.83 F7 (0.42) ALDH1A1HTR3EHTR3BHTR3ABACE1
SCHEMBL1967417 0.75 KMT2A (0.42) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL207428 0.75 ALDH1A1 (0.41) ALDH1A1BACE1DYRK1AKDM4EMAPT
SCHEMBL207131 0.75 ALPL (0.41) BACE1KDM4EKMT2AAHRMETAP2
SCHEMBL10973210 0.75 PRKCI (0.47) ALDH1A1DYRK1AHPGDSMN1; SMN2TDP1
SCHEMBL7623293 0.75 — —
SCHEMBL440275 0.74 MAPK13 (0.41) ALDH1A1DYRK1AHPGDSMN1; SMN2HSD17B10
SCHEMBL208833 0.73 DAO (0.46) ALDH1A1HPGDSMN1; SMN2TP53KDM4E
SCHEMBL3655322 0.71 PIN1 (0.44) NOS1GRIN1GRIN2BMETAP2METAP1
SCHEMBL1246822 0.71 NPBWR1 (0.44) BACE1DYRK1AKDM4EMETAP2CBFB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2362775-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2011-09-07 — — EP claimed
WO-2010059658-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-05-27 — — WO claimed
EP-1925611-B1 OPTICALLY ACTIVE DIAMINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME DAIICHI SANKYO CO LTD (JP) 2016-04-13 — — EP disclosed
CN-103333171-B Synthetic method of pyrrole [1,2-a ] quinoxaline derivative NANJING TECH UNIVERSITY (CN) 2015-10-28 — — CN disclosed
CN-103342705-A Method for synthesizing pyrrole [1,2-a ] quinoxaline derivative NANJING UNIVERSITY OF TECHNOLOGY 2013-10-09 — — CN disclosed
CN-103333171-A Synthetic method of pyrrole [1,2-a ] quinoxaline derivative NANJING UNIVERSITY OF TECHNOLOGY 2013-10-02 — — CN disclosed
EP-2431370-B1 Monoacylated 1,2-diaminocycloalkanes DAIICHI SANKYO CO LTD (JP) 2013-06-19 — — EP disclosed
EP-1577301-B1 Antithrombotic diaminocyclohexane derivatives DAIICHI SANKYO CO LTD (JP) 2012-09-12 — — EP disclosed
EP-2431370-A1 Monoacylated 1,2-diaminocycloalkanes DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2012-03-21 — — EP disclosed
US-8088796-B2 Triamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-03 — — US disclosed
US-20110312990-A1 Diamine Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-22 — — US disclosed
US-4172081-A Benzotriazole ultraviolet stabilizers EASTMAN KODAK COMPANY (US) 1979-10-23 — — US disclosed
US-4162254-A Benzoxazole ultraviolet stabilizers EASTMAN KODAK COMPANY (US) 1979-07-24 — — US disclosed
US-4137235-A ULTRAVIOLET STABILIZERS IN POLYMERIC COMPOSITIONS EASTMAN KODAK COMPANY (US) 1979-01-30 — — US disclosed
US-4116928-A Heterocylic ester, ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1978-09-26 — — US disclosed
US-4116929-A POLYESTERS EASTMAN KODAK COMPANY (US) 1978-09-26 — — US disclosed
US-4096115-A Ultraviolet light stabilized polymers EASTMAN KODAK COMPANY (US) 1978-06-20 — — US disclosed
US-4065427-A Polychromophoric heterocyclic ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1977-12-27 — — US disclosed
US-4017508-A POLYMERS EASTMAN KODAK COMPANY (US) 1977-04-12 — — US disclosed
US-4000148-A POLYMERS EASTMAN KODAK COMPANY (US) 1976-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312990-A1 Diamine Derivatives C9, C1S, C1R ALDH1A1 3734/4885HTR3E 2009/4885HTR3B 2709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback